New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Source